Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.
- NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_assertion description "[Short-term (30 min) pretreatment with forskolin (FSK; 10 muM), a direct activator of adenylyl cyclase, in combination with the cyclic nucleotide phosphodiesterase inhibitor isobutylmethylxanthine (IBMX; 200 muM), attenuated CCE in PASMC from normal subjects, patients without pulmonary hypertension (NPH), and patients with IPAH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.
- NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_assertion evidence source_evidence_literature NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.
- NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_assertion SIO_000772 17189322 NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.
- NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_assertion wasDerivedFrom befree-2016 NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.
- NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_assertion wasGeneratedBy ECO_0000203 NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.
- befree-2016 importedOn "2016-02-19" NP586025.RA-Mp-wTsu4eP_rHkumk7gr6tLfn3N53qoGEYL1ZsUm0w130_provenance.